Phillip Mertz
Director/Board Member bij ALPHA COGNITION INC.
Vermogen: 728 377 $ op 31-03-2024
Profiel
Phillip P.
Mertz is the founder of Secure Open Solutions.
He is currently the Chief Executive Officer at Subtle Technologies and the Director at Alpha Cognition, Inc. He previously worked as a Director at Alpha Cognition, Inc. Mr. Mertz received his undergraduate degree from Harvard University in 2006.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ALPHA COGNITION INC
1.43% | 29-08-2023 | 1 255 822 ( 1.43% ) | 728 377 $ | 31-03-2024 |
Actieve functies van Phillip Mertz
| Bedrijven | Functie | Begin |
|---|---|---|
| ALPHA COGNITION INC. | Director/Board Member | 22-03-2021 |
Eerdere bekende functies van Phillip Mertz
| Bedrijven | Functie | Einde |
|---|---|---|
Alpha Cognition, Inc. /old/
 Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Director/Board Member | - |
Opleiding van Phillip Mertz
| Harvard University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Health Technology |
